WT1 protein is cleaved by caspase-3 in apoptotic leukemic cells

The aberrant overexpression of Wilms' tumor-1 gene (WT1) plays an important role in blast cell survival and resistance to chemotherapy in acute myeloid leukemia (AML). Here, we found in chemotherapeutic drug etoposide-induced Apoptosis, WT1 protein was cleaved into smaller fragment by Caspase-3 in leukemic cells. The cleavage was blocked by pan-caspase inhibitor and special Caspase-3 inhibitor, suggesting that Caspase-3 might cleave WT1 protein. Furthermore, recombinant active Caspase-3 cleaved the Flag-WT1 and GST-WT1 proteins in vitro. However, site-directed mutagenesis analyses failed to identify caspase-3-targeted sites in WT1 protein, indicating that Caspase-3 cleaved uncommon sites but not classical motifs (DXXD) and non-classical motifs (XXXD). Finally, Eto decreased c-Myc and Bcl-2 expression via reducing the binding of WT1 to the promoter and Eto-induced Apoptosis was partially prevented by overexpression of WT1. Collectively, we identify a new substrate for Caspase-3 and shed new light on understanding the complicated biology of WT1 in leukemia.